FTSE - Hikma Pharmaceuticals (UK)

RNS Number:3303M
FTSE
22 January 2008

Hikma Pharmaceuticals PLC (UK): Shares In Issue UpdateChanges In FTSE Indices

22 January 2008
Following a shares in issue update for Hikma Pharmaceuticals PLC (UK) resulting from a placing and updated information
from the company, FTSE announces the following changes:

INDEX CHANGE EFFECTIVE FROMSTART OF
TRADING
FTSE 250 Hikma Pharmaceuticals (UK B0LCW08) will remain 30 January 2008
in the index with an increased shares in issue
total of 188,037,607 and an unchanged
investability weighting of 75%.
FTSE All-Share Hikma Pharmaceuticals will be treated as above. 30 January 2008
FTSE All-Share Ex-Multinationals Hikma Pharmaceuticals will be treated as above. 30 January 2008
FTSE 350 - Lower Yield Hikma Pharmaceuticals will be treated as above. 30 January 2008

FREE TRIAL: FTSE Global Equity Index Series emerging markets indices are segmented by Advanced Emerging and Secondary
Emerging, and by large, mid, small and aggregate indices, for as granular an analysis as you require. Our emerging
markets expertise is further demonstrated by the range of indices we produce in association with high calibre local
partners - Xinhua, JSE and TSEC. We are offering a one month free trial of FTSE GEIS, FTSE Xinhua, FTSE JSE and TSEC
Taiwan Indices via one of our vendors or directly from FTSE Group. To find out more please visit our website at
www.ftse.com/emergingmarkets

For index related enquiries or further information about FTSE please contact:
Client Services in UK: Tel: +44 (0) 20 7866 1810
Client Services in US: Tel: +1 888 747 FTSE (3873) or +1 212 641 6165
Client Services in Asia Pacific: Tel: +852 2230 5803 or +65 6223 3738 or +81 3 3581 2811

Or, email your enquiries to info@ftse.com or visit our website at www.ftse.com
Terms of Use | Copyright (c) FTSE

This information is provided by RNS
The company news service from the London Stock Exchange
END

FTSBTMRTMMITBMP